Business
BioSpectrum Asia
Guinea introduces malaria vaccine into routine immunisation
Under the leadership of the Ministry of Health and Public Hygiene, and with the support of Gavi, the Vaccine Alliance, the World Health Organization (WHO), UNICEF and PATH, Guinea has officially introduced the malaria vaccine into its Expanded Programme on Immunisation (EPI).
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Dx&Vx signs $220 M pact with US firm for mRNA cancer vaccine development
South Korea-based Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Singapore develops blood test to improve prediction of gestational diabetes
Researchers from the Global Centre for Asian Women's Health (GloW) and the Department of Obstetrics and Gynecology at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have found that selected maternal biomarkers from first-trimester random blood samples can effectively predict a woman's risk of gestational diabetes mellitus (GDM).
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Singapore's Health Sciences Authority signs MoU with Hong Kong Department of Health
Singapore's Health Sciences Authority (HSA) and the Department of Health (DOH), Hong Kong Special Administrative Region (HKSAR), have signed a Memorandum of Understanding (MoU) for cooperation in healthcare regulatory matters pertaining to health products.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
WHO urges action on hepatitis, announcing hepatitis D as carcinogenic
The World Health Organisation (WHO) calls on governments and partners to urgently accelerate efforts to eliminate viral hepatitis as a public health threat and reduce liver cancer deaths.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Korea explores possibility of developing next-gen drugs for neurodegenerative diseases
Herpotrichone is a natural substance that has been evaluated highly for its excellent ability to suppress inflammation in the brain and protect nerve cells, displaying significant potential to be developed as a therapeutic agent for neurodegenerative brain diseases such as Alzheimer's disease and Parkinson's disease.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Thermo Fisher launches Scios 3 and Talos 12 Electron Microscopes
Thermo Fisher Scientific has announced the launch of two new electron microscopes.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Mirugen secures upto A$4.5 M seed funding for pioneering cell reprogramming
Mirugen, a preclinical biotechnology startup (re)programming cells to unlock innate cellular repair mechanisms, has announced the successful close of a seed financing round, and the appointment of Charlotte Casebourne Stock as Executive Chair.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
"We aim to position Korea among the global top 3 in clinical trial competitiveness and establish it as Asia's central research hub"
With streamlined regulatory pathways, globally aligned infrastructure, and strong patient engagement, Korea is fast emerging as a preferred hub for clinical development in Asia. At the centre of this shift is KoNECT — a government-funded, nonprofit organisation under the Ministry of Health and Welfare of Korea tasked with accelerating both domestic and global clinical trial activity. President Dr. Inseok Park discusses how the agency is driving international investment, deepening cross-border collaborations, and preparing Korea’s research workforce for the next phase of global clinical trials. Edited excerpts:
4 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Why TPD Is Biotech's Next Big Bet
Targeted Protein Degradation (TPD) is an emerging therapeutic approach that allows the removal of disease-causing proteins once considered 'undruggable'.
9 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Australia invests $21.5 M to strengthen aged care workforce
The Australian government is backing its dedicated aged care workforce across Australia, investing $21.5 million in scholarships to help aged care workers and nurses progress in their careers.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Hong Kong conducts study to reshape treatment landscape for hepatocellular carcinoma
Researchers from the School of Biomedical Sciences at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have made a significant advancement that could reshape the treatment landscape for hepatocellular carcinoma (HCC), the most common type of liver cancer, which often resists treatment and recurs.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Hong Kong-Australia collaboration for advancing clinical education in physiotherapy
The Department of Rehabilitation Sciences at The Hong Kong Polytechnic University (PolyU) recently hosted the inaugural Clinical Education Conference, the first event of its kind in Hong Kong, aiming to promote the advancement of clinical education in physiotherapy and occupational therapy.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
National University of Singapore inks healthcare MoU with Germany's Robert Koch Institute
The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Robert Koch Institute (RKI), Berlin, Germany have entered a strategic partnership with the signing of a Memorandum of Understanding (MoU) to collaborate on joint operations in scientific, academic and training initiatives, focusing on pandemic preparedness and public health.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Olympus joins hand with Revival Healthcare to develop endoluminal gastrointestinal robotics
Japan-based medtech company Olympus Corporation has signed a partnership with Revival Healthcare Capital to advance endoluminal robotics.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Hong Kong Betting Big on Biotech IPOs
Hong Kong has become one of the preferred destinations for biotech IPOs, attracting both mainland Chinese and international firms.
5 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Alloy Therapeutics partners with Kansai Startup Academia Coalition in Japan
Alloy Therapeutics Co.has announced the signing of a Memorandum of Understanding (MoU) with the Kansai Startup Academia Coalition (KSAC), represented by Kyoto University, to foster the global expansion of university-affiliated life science startups across Japan.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Agilent expands Dako Omnis Family with 3 new models to meet evolving pathology lab needs
Agilent Technologies Inc. has announced the introduction of its Agilem Dako Omnis family of instruments with three new models- Agilent Dako Omnis 110, 165, and 165 Duo- designed to meet the evolving needs of pathology laboratories of all sizes.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Cohance Lifesciences invests $10 M in cGMP Bioconjugation Suite in US
India-based Cohance Lifesciences, a leading global Contract Research, Development & Manufacturing Organisation (CRDMO), has announced a strategic investment of $10 million to expand cGMP bioconjugation capabilities at its US based subsidiary, NJ Bio.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
"APAC is one of the fastestgrowing photodynamic therapy markets globally"
Australia's Invion Group is emerging as a leader in the development of next generation precision photodynamic technology (PDT), known as Photosoft, for a range of cancers and other diseases. The minimally invasive treatment promises to provide a potentially more affordable option for millions of people in developed and developing markets. At the recently held BioAsia Taiwan 2025 event, which highlighted the ongoing demand for precision oncology solutions in underserved Asian markets, BioSpectrum Asia took the opportunity to interact with Thian Chew, Chief Executive Officer, Invion Group to find out more about how the company is revolutionising the oncology market with its new products and technology. Edited excerpts
4 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Frencken marks groundbreaking for new facility worth S$63 M in Singapore
Frencken Group Limited, a global integrated technology solutions company, recently held a groundbreaking ceremony at the site of its upcoming manufacturing facility in Kaki Bukit Avenue 5, Singapore.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Addressing Widespread Mental Health Disorders
World Mental Health Day, observed annually on October 10, is a global campaign designed to spotlight mental health issues and inspire collective action to improve access to care. It offers a crucial moment for governments, health professionals, advocates, and communities to showcase progress, identify gaps, and call for stronger commitments to ensure mental health support is available for everyone. The urgency is because mental health conditions remain widespread and under-treated, creating significant health, social, and economic burdens.
2 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Quasar Medical unveils new global headquarters in Singapore
Quasar Medical, a global leader in manufacturing interventional and minimally invasive medical devices, has announced the opening of its Global Headquarters in Singapore.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
CEPI & PATH join hands to create playbooks to map immune markers in deadly diseases
The global health organisations Coalition for Epidemic Preparedness Innovations (CEPI) and Program for Appropriate Technology in Health (PATH) are joining forces to create pivotal playbooks that map all available research into specific immune markers that indicate protection against target viruses with epidemic or pandemic potential.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
AusBiotech on-boards Kerri Lee Sinclair as new Head of Investment
AusBiotech has announced the appointment of Kerri Lee Sinclair as its new Head of Investment, marking a significant step in strengthening investor engagement across Australia's life sciences sector.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Japan predicts stem cell-derived organoid quality with machine learning
A research team at Kyoto University, Japan has developed a machine learning model that enables early prediction of hypothalamus-pituitary organoid formation from human Induced pluripotent stem (iPS) cells, thus aiding organoid research and regenerative medicine.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Africa CDC and European Commission to strengthen Mpox testing
The Africa Centres for Disease Control and Prevention (Africa CDC) and the European Commission have announced the launch of the Partnership to Accelerate Mpox Testing and Sequencing in Africa (PAMTA), a landmark initiative to boost diagnostics and outbreak response capabilities in Mpox-affected African countries.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Kenya eliminates Human African Trypanosomiasis as public health problem
Kenya's Ministry of Health (MoH) recently announced that the country has successfully eliminated human African trypanosomiasis (HAT), commonly known as \"sleeping sickness\", as a public health problem.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Japan launches nationwide gastric health initiative
In a significant advancement for public health, Japan's 93rd Prime Minister Yukio Hatoyama has launched a nationwide public health initiative focused on gastric health and early detection of gastric cancer.
1 min |
BioSpectrum Asia Sep 2025
BioSpectrum Asia
APAC focuses on bridging eye care gaps
Roche APAC Vision Health Survey in 2025 reveals a stark disconnect between vision health concerns and preventive action across Asia Pacific (APAC) - while 91 per cent of adults over 40 express concerns about their vision health, only 28 per cent report undergoing annual or more frequent eye exams.
5 min |